Thus, compensatory changes in other NMNAT isoforms or NMNAT enzyme activity are unlikely to account for our failure to observe alterations in chemotherapy-induced peripheral neuropathy in NMNAT2+/- mice. Here, NMNAT2 is linked to peripheral neuropathy.